The global Organoids market size was valued at US$ 68.9 million in 2024 and is forecast to a readjusted size of USD 217 million by 2031 with a CAGR of 18.0% during review period.
Organoids are in-vitro derived 3D cell aggregates derived from primary tissue or stem cells that are capable of self-renewal, self-organization and exhibit organ functionality.
Organoids are a complex collection of cells grown in 3D culture medium that can summarize the various physiological and genomic characteristics of various tissues or organs. Organoids are micro-organs with three-dimensional structures that are cultivated in vitro using adult stem cells. They have highly similar genetic backgrounds and histological characteristics to organs in the body; they have complex structures similar to real organs and can partially simulate the physiological functions of the source tissues and organs; they simulate the endogenous environment to conduct research on tissue biology, development and regeneration, disease modeling, organ transplantation technology improvement, drug discovery/efficacy evaluation, and toxicology. Organoids refer to tissue analogs with a certain spatial structure formed by three-dimensional (3D) culture in vitro using adult stem cells or pluripotent stem cells. Although organoids are not true human organs, they can simulate real organs in structure and function, can simulate the structure and function of in vivo tissues to the greatest extent, and can be cultured stably for a long time (hence they are also called "micro-organs").
A major driver of the organoids market is the increasing demand for advanced models in drug discovery and personalized medicine. Organoids, which mimic the structure and function of real human organs, provide a more accurate representation of human biology compared to traditional cell cultures or animal models. This enables pharmaceutical companies to conduct more precise preclinical testing, reducing the time and cost of drug development. Additionally, organoids are being increasingly used in personalized medicine, where they can help tailor treatments to individual patients by predicting how they will respond to specific therapies, particularly in cancer research.
One of the main challenges in the organoids market is the complexity and high cost of organoid development and maintenance. Creating organoids that accurately replicate human organs requires sophisticated techniques and specialized equipment, making the process expensive and technically demanding. Additionally, there are still limitations in scaling up production and standardizing protocols, which hinders widespread adoption in clinical settings. Regulatory hurdles and the need for more validation studies to ensure the reliability of organoids in predicting human responses also pose barriers to market growth.
This report is a detailed and comprehensive analysis for global Organoids market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Organoids market size and forecasts, in consumption value ($ Million), 2020-2031
Global Organoids market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Organoids market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Organoids market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Organoids
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Organoids market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Merck, Corning, STEMCELL Technologies, Lonza, Prellis Biologics, amsbio, Tanwang Medical, Ketu Medicine, Chuangxin International, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 segmentation
Organoids market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Stem Cell Source
Tumor Cell Source
麻豆原创 segment by Application
Precision Medicine
Pharmaceutical R&D
Academics and Research Institutes
麻豆原创 segment by players, this report covers
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Organoids product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Organoids, with revenue, gross margin, and global market share of Organoids from 2020 to 2025.
Chapter 3, the Organoids competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Organoids market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Organoids.
Chapter 13, to describe Organoids research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Organoids by Type
1.3.1 Overview: Global Organoids 麻豆原创 Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Organoids Consumption Value 麻豆原创 Share by Type in 2024
1.3.3 Stem Cell Source
1.3.4 Tumor Cell Source
1.4 Global Organoids 麻豆原创 by Application
1.4.1 Overview: Global Organoids 麻豆原创 Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Precision Medicine
1.4.3 Pharmaceutical R&D
1.4.4 Academics and Research Institutes
1.5 Global Organoids 麻豆原创 Size & Forecast
1.6 Global Organoids 麻豆原创 Size and Forecast by Region
1.6.1 Global Organoids 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Organoids 麻豆原创 Size by Region, (2020-2031)
1.6.3 North America Organoids 麻豆原创 Size and Prospect (2020-2031)
1.6.4 Europe Organoids 麻豆原创 Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Organoids 麻豆原创 Size and Prospect (2020-2031)
1.6.6 South America Organoids 麻豆原创 Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Organoids 麻豆原创 Size and Prospect (2020-2031)
2 Company Profiles
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Organoids Product and Solutions
2.1.4 Thermo Fisher Scientific Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Organoids Product and Solutions
2.2.4 Merck Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Merck Recent Developments and Future Plans
2.3 Corning
2.3.1 Corning Details
2.3.2 Corning Major Business
2.3.3 Corning Organoids Product and Solutions
2.3.4 Corning Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Corning Recent Developments and Future Plans
2.4 STEMCELL Technologies
2.4.1 STEMCELL Technologies Details
2.4.2 STEMCELL Technologies Major Business
2.4.3 STEMCELL Technologies Organoids Product and Solutions
2.4.4 STEMCELL Technologies Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 STEMCELL Technologies Recent Developments and Future Plans
2.5 Lonza
2.5.1 Lonza Details
2.5.2 Lonza Major Business
2.5.3 Lonza Organoids Product and Solutions
2.5.4 Lonza Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Lonza Recent Developments and Future Plans
2.6 Prellis Biologics
2.6.1 Prellis Biologics Details
2.6.2 Prellis Biologics Major Business
2.6.3 Prellis Biologics Organoids Product and Solutions
2.6.4 Prellis Biologics Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Prellis Biologics Recent Developments and Future Plans
2.7 amsbio
2.7.1 amsbio Details
2.7.2 amsbio Major Business
2.7.3 amsbio Organoids Product and Solutions
2.7.4 amsbio Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 amsbio Recent Developments and Future Plans
2.8 Tanwang Medical
2.8.1 Tanwang Medical Details
2.8.2 Tanwang Medical Major Business
2.8.3 Tanwang Medical Organoids Product and Solutions
2.8.4 Tanwang Medical Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Tanwang Medical Recent Developments and Future Plans
2.9 Ketu Medicine
2.9.1 Ketu Medicine Details
2.9.2 Ketu Medicine Major Business
2.9.3 Ketu Medicine Organoids Product and Solutions
2.9.4 Ketu Medicine Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 Ketu Medicine Recent Developments and Future Plans
2.10 Chuangxin International
2.10.1 Chuangxin International Details
2.10.2 Chuangxin International Major Business
2.10.3 Chuangxin International Organoids Product and Solutions
2.10.4 Chuangxin International Organoids Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Chuangxin International Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Organoids Revenue and Share by Players (2020-2025)
3.2 麻豆原创 Share Analysis (2024)
3.2.1 麻豆原创 Share of Organoids by Company Revenue
3.2.2 Top 3 Organoids Players 麻豆原创 Share in 2024
3.2.3 Top 6 Organoids Players 麻豆原创 Share in 2024
3.3 Organoids 麻豆原创: Overall Company Footprint Analysis
3.3.1 Organoids 麻豆原创: Region Footprint
3.3.2 Organoids 麻豆原创: Company Product Type Footprint
3.3.3 Organoids 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Organoids Consumption Value and 麻豆原创 Share by Type (2020-2025)
4.2 Global Organoids 麻豆原创 Forecast by Type (2026-2031)
5 麻豆原创 Size Segment by Application
5.1 Global Organoids Consumption Value 麻豆原创 Share by Application (2020-2025)
5.2 Global Organoids 麻豆原创 Forecast by Application (2026-2031)
6 North America
6.1 North America Organoids Consumption Value by Type (2020-2031)
6.2 North America Organoids 麻豆原创 Size by Application (2020-2031)
6.3 North America Organoids 麻豆原创 Size by Country
6.3.1 North America Organoids Consumption Value by Country (2020-2031)
6.3.2 United States Organoids 麻豆原创 Size and Forecast (2020-2031)
6.3.3 Canada Organoids 麻豆原创 Size and Forecast (2020-2031)
6.3.4 Mexico Organoids 麻豆原创 Size and Forecast (2020-2031)
7 Europe
7.1 Europe Organoids Consumption Value by Type (2020-2031)
7.2 Europe Organoids Consumption Value by Application (2020-2031)
7.3 Europe Organoids 麻豆原创 Size by Country
7.3.1 Europe Organoids Consumption Value by Country (2020-2031)
7.3.2 Germany Organoids 麻豆原创 Size and Forecast (2020-2031)
7.3.3 France Organoids 麻豆原创 Size and Forecast (2020-2031)
7.3.4 United Kingdom Organoids 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Russia Organoids 麻豆原创 Size and Forecast (2020-2031)
7.3.6 Italy Organoids 麻豆原创 Size and Forecast (2020-2031)
8 Asia-Pacific
8.1 Asia-Pacific Organoids Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Organoids Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Organoids 麻豆原创 Size by Region
8.3.1 Asia-Pacific Organoids Consumption Value by Region (2020-2031)
8.3.2 China Organoids 麻豆原创 Size and Forecast (2020-2031)
8.3.3 Japan Organoids 麻豆原创 Size and Forecast (2020-2031)
8.3.4 South Korea Organoids 麻豆原创 Size and Forecast (2020-2031)
8.3.5 India Organoids 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Southeast Asia Organoids 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Australia Organoids 麻豆原创 Size and Forecast (2020-2031)
9 South America
9.1 South America Organoids Consumption Value by Type (2020-2031)
9.2 South America Organoids Consumption Value by Application (2020-2031)
9.3 South America Organoids 麻豆原创 Size by Country
9.3.1 South America Organoids Consumption Value by Country (2020-2031)
9.3.2 Brazil Organoids 麻豆原创 Size and Forecast (2020-2031)
9.3.3 Argentina Organoids 麻豆原创 Size and Forecast (2020-2031)
10 Middle East & Africa
10.1 Middle East & Africa Organoids Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Organoids Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Organoids 麻豆原创 Size by Country
10.3.1 Middle East & Africa Organoids Consumption Value by Country (2020-2031)
10.3.2 Turkey Organoids 麻豆原创 Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Organoids 麻豆原创 Size and Forecast (2020-2031)
10.3.4 UAE Organoids 麻豆原创 Size and Forecast (2020-2031)
11 麻豆原创 Dynamics
11.1 Organoids 麻豆原创 Drivers
11.2 Organoids 麻豆原创 Restraints
11.3 Organoids Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Organoids Industry Chain
12.2 Organoids Upstream Analysis
12.3 Organoids Midstream Analysis
12.4 Organoids Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Thermo Fisher Scientific
Merck
Corning
STEMCELL Technologies
Lonza
Prellis Biologics
amsbio
Tanwang Medical
Ketu Medicine
Chuangxin International
听
听
*If Applicable.
